Memorial Sloan Kettering Cancer Center 13F Holdings · last filed Q3 2023
Memorial Sloan Kettering Cancer Center reported 3 securities worth $24.56M in its SEC 13F filing for Q3 2023 (period ended 2023-09-30). Top holdings: GDX (80.92%), ORIC (14.84%), YMAB (4.24%). Among its top 25 positions this quarter: 2 exited.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | GDX | VANECK ETF TRUST | $19.9M | 80.92% | 738,500 | Hold |
| 2 | ORIC | ORIC PHARMACEUTICALS INC | $3.6M | 14.84% | 602,272 | Hold |
| 3 | YMAB | Y-MABS THERAPEUTICS INC | $1.0M | 4.24% | 191,176 | Hold |
| 4 | CRBU | CARIBOU BIOSCIENCES INC | $0 | 0.00% | 0 | Exited |
| 5 | ILMN | ILLUMINA INC | $0 | 0.00% | 0 | Exited |
Source: SEC Form 13F filings · as of 2023-09-30
Every position in this 13F-HR, with its change from the prior quarter.
13F holdings, latest quarter
SourceSEC EDGAR13F-HR